High blood pressure & cardiovascular prevention.
2019 ;
26 (2) :
85-100.
[pub] 20190315
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.
- MeSH
- anticholesteremika škodlivé účinky terapeutické užití MeSH
- ateroskleróza krev diagnóza farmakoterapie mortalita MeSH
- biologické markery krev MeSH
- cholesterol krev MeSH
- chování snižující riziko MeSH
- cvičení MeSH
- dyslipidemie krev diagnóza farmakoterapie mortalita MeSH
- lidé MeSH
- ochranné faktory MeSH
- rizikové faktory MeSH
- triglyceridy krev MeSH
- výsledek terapie MeSH
- zdravá strava MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
